MRTX - Mirati Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5436.45M
Enterprise Value 3385.73M
Trailing P/E N/A
Forward P/E 1-6.87
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.19
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-5.25

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin 0.00%
Operating Margin (ttm)0.00%
Management Effectiveness
Return on Assets (ttm)-48.20%
Return on Equity (ttm)-91.23%
Income Statement
Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -73.47M
Net Income Avi to Common (ttm)-75.33M
Diluted EPS (ttm)-3.38
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)88.69M
Total Cash Per Share (mrq)3.55
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.86
Book Value Per Share (mrq)3.32
Cash Flow Statement
Operating Cash Flow (ttm)-70.27M
Levered Free Cash Flow (ttm)-40.71M

Trading Information

Stock Price History
Beta 1.37
52-Week Change 3222.03%
S&P500 52-Week Change 317.63%
52 Week High 319.25
52 Week Low 32.70
50-Day Moving Average 314.17
200-Day Moving Average 37.17
Share Statistics
Avg Vol (3 month) 31.43M
Avg Vol (10 day) 3853.79k
Shares Outstanding 525.3M
Float 14.42M
% Held by Insiders 11.73%
% Held by Institutions 164.81%
Shares Short 31.12M
Short Ratio 35.41
Short % of Float 36.20%
Shares Short (prior month) 3797.05k
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A